内TREX1诱导通过限制I型IFNN来促进免疫逃避
Eléonore Toufektchan1, Alexandra Dananberg1, Josefine Striepen1
1Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer immunology research
|February 26, 2024
概括
癌症中的染色体不稳定性可以触发免疫反应. 这项研究揭示了TREX1酶的上调有助于瘤通过降解DNA来逃避检测,突出了TREX1作为潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 染色体不稳定性 (CIN) 是人类侵袭性癌症的一个关键特征.
- CIN可以导致细胞质DNA的积累,激活cGAS-STING先天免疫路径.
- 没有完全理解CIN瘤逃避免疫监测的机制.
研究的目的:
- 研究TREX1在控制癌症染色体不稳定引发的免疫反应中的作用.
- 确定TREX1是否在染色体不稳定的瘤中起到免疫逃避机制的作用.
主要方法:
- 与染色体不稳定性和免疫反应相关的TREX1表达的分析.
- 在瘤模型中对TREX1水平的实验操纵.
- 评估瘤生长,宿主存活率,免疫透和对免疫治疗的反应.
主要成果:
- cGAS-STING通路的激活导致TREX1上调,从而降解细胞质DNA.
- 失去TREX1会减少瘤生长,改善宿主存活率,并增加抗瘤免疫细胞的透.
- 在依赖STING的瘤中,TREX1抑制增强了对免疫检查点阻塞的反应.
结论:
- TREX1作为一个关键的负反机制,使染色体不稳定的瘤能够通过减少I型干扰素的产生来逃避免疫监测.
- 向TREX1可能为癌症提供选择性治疗策略,这些癌症具有完整的STING介导干扰素反应.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
749
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910